FDA updates in urology: October 2025

Welcome to Urology Times’® monthly FDA update! This month’s notable regulatory decisions reflected the innovation coming down the pike, with a focus on priority reviews, fast track designations, and breakthrough device designations. From advancing next-generation therapeutics for bladder and prostate cancer to progressing minimally invasive technologies for stone disease, these updates underscore the ongoing progress across the spectrum of urologic care.